USPTO serial 79238743
ORPHANEXT
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- ORNDORFF, LINDA
- Law office
- TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ORPHANEXT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Compilation and management of databases and central data files in the field of pharmaceutical research and development, scientific research relating to medicine, medicine and clinical trials; compilation of statistics; collection and systematization of data in a central file; public relations | SECTION 70 - CANCELLED | — |
| 041 | Training services; publication of books and texts other than advertising texts; electronic publication of texts in the field of pharmaceutical research and development, scientific research regarding medicine, online medicine; organization and conducting of colloquiums, conferences, congresses, seminars in the pharmaceutical and medical sector; teaching; information and awareness program on the treatment of diseases (education services) | SECTION 70 - CANCELLED | — |
| 042 | Pharmaceutical research and development; scientific research regarding medicine; conducting of clinical trials and studies; chemical and biological analysis; research in chemistry, cosmetology, biology, bacteriology, nutrition and biotechnology; biological research for the diagnosis, prevention and treatment of neurodegenerative, metabolic, inflammatory, cancerous and cardiac diseases, diabetes and obesity and any other diseases; biological research services in the field of chemical, biological and pharmaceutical products; design and development of software; scientific laboratory services; scientific research for chemical reagents for medical use, namely, biomarkers; creation (design) of databases and central data files in the field of pharmaceutical research and development, scientific research relating to medicine, medicine and clinical trials; providing information relating to medical and scientific research in the field of pharmaceutical products and clinical trials | SECTION 70 - CANCELLED | — |
| 044 | Providing information relating to pharmaceutical products in the field of pharmaceutical products and clinical trials | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 1, 2018 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 30, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 21, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 4, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 4, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 25, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 23, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 22, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 21, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 16, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |